BM-1244, CAS [[1619923-32-8]]

Produktübersicht

• Artikelname: BM-1244, CAS [[1619923-32-8]]
• Artikelnummer: MCE-HY-138832
• Hersteller Artikelnummer: HY-138832
• Alternativnummer: MCE-HY-138832-1MG,MCE-HY-138832-10MG,MCE-HY-138832-25MG,MCE-HY-138832-5MG,MCE-HY-138832-10MMX1ML
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: APG-1252-M1

Produktbeschreibung

BM-1244 (APG-1252-M1) is a Bcl-xL/Bcl-2 inhibitor with Kis of 134 nM and 450 nM. BM-1244 has anti-tumor effects by inducing apoptosis and suppressing tumor growth. BM-1244 can induce cytochrome C and Smac release from mitochondria with caspase-3 and PARP cleavage. BM-1244 exhibits synergy with chemotherapy in vivo. BM-1244 can be studied in research for colorectal cancer, acute myeloid leukemia and gastric cancer[1][2][3].

Produkteigenschaften

• Molekulargewicht: 1159.79
• Reinheit: 99.85
• CAS Nummer: [1619923-32-8]
• Formel: C54H59ClF4N6O8S4
• Target-Kategorie: Apoptosis,Bcl-2 Family,Caspase,PARP

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound